Loading…
Uterine papillary serous carcinoma: study of 19 cases
Objective: Uterine papillary serous carcinoma (UPSC) is an uncommon highly malignant variant of endometrial carcinoma that histologically and clinically resembles ovarian papillary serous carcinoma. The purpose of this study was to present the conjoined experience of two regional hospitals in the so...
Saved in:
| Published in: | European journal of obstetrics & gynecology and reproductive biology 1998-07, Vol.79 (1), p.69-73 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c389t-4df85de995a664e37c2dd3da41f343b11f3fe34bb4b40e42d8a86e9ef502d6933 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c389t-4df85de995a664e37c2dd3da41f343b11f3fe34bb4b40e42d8a86e9ef502d6933 |
| container_end_page | 73 |
| container_issue | 1 |
| container_start_page | 69 |
| container_title | European journal of obstetrics & gynecology and reproductive biology |
| container_volume | 79 |
| creator | Piura, Benjamin Meirovitz, Mihai Shmulman, Michael Yanai-Inbar, Ilana Cohen, Yoram Dgani, Ram |
| description | Objective: Uterine papillary serous carcinoma (UPSC) is an uncommon highly malignant variant of endometrial carcinoma that histologically and clinically resembles ovarian papillary serous carcinoma. The purpose of this study was to present the conjoined experience of two regional hospitals in the south of Israel (Soroka Medical Center, Beer-Sheva and Kaplan Hospital, Rehovot) of handling this tumour.
Study Design: Data from the files of 19 patients with UPSC who were managed at these hospitals between July 1991 and June 1997 were evaluated.
Results: The three-year survival rate was 57.3% overall; 83.3% for Stage I and 21.2% for Stages II, III, and IV combined (
P |
| doi_str_mv | 10.1016/S0301-2115(98)00039-6 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79965076</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0301211598000396</els_id><sourcerecordid>79965076</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-4df85de995a664e37c2dd3da41f343b11f3fe34bb4b40e42d8a86e9ef502d6933</originalsourceid><addsrcrecordid>eNqFkE1LxDAQhoMo67r6E4QeRPRQTZqPNl5EFr9gwYPuOaTJFCL9MukK--9Nd8tePQ1knpl58yB0SfAdwUTcf2KKSZoRwm9kcYsxpjIVR2hOijxLc8HZMZofkFN0FsI3HikqZ2gmBaMM53PE1wN410LS697VtfbbJIDvNiEx2hvXdo1-SMKwsdukqxIi43OAcI5OKl0HuJjqAq1fnr-Wb-nq4_V9-bRKDS3kkDJbFdyClFwLwYDmJrOWWs1IRRktSSwVUFaWrGQYWGYLXQiQUHGcWSEpXaDr_d7edz8bCINqXDAQc7YQM6pcSsFxLiLI96DxXQgeKtV718TfKILVqEvtdKnRhZKF2ulS49zldGBTNmAPU5Of2L-a-joYXVdet8aFA5ZlnHI25nzcYxBl_DrwKhgHrQHrPJhB2c79E-QPNIeFUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79965076</pqid></control><display><type>article</type><title>Uterine papillary serous carcinoma: study of 19 cases</title><source>ScienceDirect Freedom Collection</source><creator>Piura, Benjamin ; Meirovitz, Mihai ; Shmulman, Michael ; Yanai-Inbar, Ilana ; Cohen, Yoram ; Dgani, Ram</creator><creatorcontrib>Piura, Benjamin ; Meirovitz, Mihai ; Shmulman, Michael ; Yanai-Inbar, Ilana ; Cohen, Yoram ; Dgani, Ram</creatorcontrib><description>Objective: Uterine papillary serous carcinoma (UPSC) is an uncommon highly malignant variant of endometrial carcinoma that histologically and clinically resembles ovarian papillary serous carcinoma. The purpose of this study was to present the conjoined experience of two regional hospitals in the south of Israel (Soroka Medical Center, Beer-Sheva and Kaplan Hospital, Rehovot) of handling this tumour.
Study Design: Data from the files of 19 patients with UPSC who were managed at these hospitals between July 1991 and June 1997 were evaluated.
Results: The three-year survival rate was 57.3% overall; 83.3% for Stage I and 21.2% for Stages II, III, and IV combined (
P<0.02). Eighteen patients had primary surgery which included total abdominal hysterectomy and bilateral salpingo-oophorectomy and 15 (83.3%) of them received postoperative adjuvant therapy which included radiotherapy and/or systemic chemotherapy.
Conclusions: The prognosis of patients with UPSC is worse than that of patients with other forms of endometrial carcinoma. Primary surgery comprised of total abdominal hysterectomy, bilateral salpingo-oophorectomy and staging is the mainstay of treatment. The type of postoperative treatment is not consistent. By and large, adjuvant pelvic radiotherapy is usually given in early-stage disease and adjuvant systemic chemotherapy is usually prescribed in advanced-stage disease.</description><identifier>ISSN: 0301-2115</identifier><identifier>EISSN: 1872-7654</identifier><identifier>DOI: 10.1016/S0301-2115(98)00039-6</identifier><identifier>PMID: 9643407</identifier><identifier>CODEN: EOGRAL</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adjuvant therapy ; Adult ; Aged ; Aged, 80 and over ; Animals ; Biological and medical sciences ; Combined Modality Therapy ; Cystadenocarcinoma, Papillary - diagnosis ; Cystadenocarcinoma, Papillary - therapy ; Endometrial carcinoma ; Ethnic Groups ; Female ; Follow-Up Studies ; Humans ; Logistic Models ; Medical sciences ; Middle Aged ; Papillary serous carcinoma ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the genital tract and mammary gland ; Surgical stage ; Survival Rate ; Tropical medicine ; Uterine Neoplasms - diagnosis ; Uterine Neoplasms - therapy</subject><ispartof>European journal of obstetrics & gynecology and reproductive biology, 1998-07, Vol.79 (1), p.69-73</ispartof><rights>1998 Elsevier Science Ireland Ltd</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-4df85de995a664e37c2dd3da41f343b11f3fe34bb4b40e42d8a86e9ef502d6933</citedby><cites>FETCH-LOGICAL-c389t-4df85de995a664e37c2dd3da41f343b11f3fe34bb4b40e42d8a86e9ef502d6933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2253543$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9643407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Piura, Benjamin</creatorcontrib><creatorcontrib>Meirovitz, Mihai</creatorcontrib><creatorcontrib>Shmulman, Michael</creatorcontrib><creatorcontrib>Yanai-Inbar, Ilana</creatorcontrib><creatorcontrib>Cohen, Yoram</creatorcontrib><creatorcontrib>Dgani, Ram</creatorcontrib><title>Uterine papillary serous carcinoma: study of 19 cases</title><title>European journal of obstetrics & gynecology and reproductive biology</title><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><description>Objective: Uterine papillary serous carcinoma (UPSC) is an uncommon highly malignant variant of endometrial carcinoma that histologically and clinically resembles ovarian papillary serous carcinoma. The purpose of this study was to present the conjoined experience of two regional hospitals in the south of Israel (Soroka Medical Center, Beer-Sheva and Kaplan Hospital, Rehovot) of handling this tumour.
Study Design: Data from the files of 19 patients with UPSC who were managed at these hospitals between July 1991 and June 1997 were evaluated.
Results: The three-year survival rate was 57.3% overall; 83.3% for Stage I and 21.2% for Stages II, III, and IV combined (
P<0.02). Eighteen patients had primary surgery which included total abdominal hysterectomy and bilateral salpingo-oophorectomy and 15 (83.3%) of them received postoperative adjuvant therapy which included radiotherapy and/or systemic chemotherapy.
Conclusions: The prognosis of patients with UPSC is worse than that of patients with other forms of endometrial carcinoma. Primary surgery comprised of total abdominal hysterectomy, bilateral salpingo-oophorectomy and staging is the mainstay of treatment. The type of postoperative treatment is not consistent. By and large, adjuvant pelvic radiotherapy is usually given in early-stage disease and adjuvant systemic chemotherapy is usually prescribed in advanced-stage disease.</description><subject>Adjuvant therapy</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Combined Modality Therapy</subject><subject>Cystadenocarcinoma, Papillary - diagnosis</subject><subject>Cystadenocarcinoma, Papillary - therapy</subject><subject>Endometrial carcinoma</subject><subject>Ethnic Groups</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Logistic Models</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Papillary serous carcinoma</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the genital tract and mammary gland</subject><subject>Surgical stage</subject><subject>Survival Rate</subject><subject>Tropical medicine</subject><subject>Uterine Neoplasms - diagnosis</subject><subject>Uterine Neoplasms - therapy</subject><issn>0301-2115</issn><issn>1872-7654</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LxDAQhoMo67r6E4QeRPRQTZqPNl5EFr9gwYPuOaTJFCL9MukK--9Nd8tePQ1knpl58yB0SfAdwUTcf2KKSZoRwm9kcYsxpjIVR2hOijxLc8HZMZofkFN0FsI3HikqZ2gmBaMM53PE1wN410LS697VtfbbJIDvNiEx2hvXdo1-SMKwsdukqxIi43OAcI5OKl0HuJjqAq1fnr-Wb-nq4_V9-bRKDS3kkDJbFdyClFwLwYDmJrOWWs1IRRktSSwVUFaWrGQYWGYLXQiQUHGcWSEpXaDr_d7edz8bCINqXDAQc7YQM6pcSsFxLiLI96DxXQgeKtV718TfKILVqEvtdKnRhZKF2ulS49zldGBTNmAPU5Of2L-a-joYXVdet8aFA5ZlnHI25nzcYxBl_DrwKhgHrQHrPJhB2c79E-QPNIeFUQ</recordid><startdate>19980701</startdate><enddate>19980701</enddate><creator>Piura, Benjamin</creator><creator>Meirovitz, Mihai</creator><creator>Shmulman, Michael</creator><creator>Yanai-Inbar, Ilana</creator><creator>Cohen, Yoram</creator><creator>Dgani, Ram</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980701</creationdate><title>Uterine papillary serous carcinoma: study of 19 cases</title><author>Piura, Benjamin ; Meirovitz, Mihai ; Shmulman, Michael ; Yanai-Inbar, Ilana ; Cohen, Yoram ; Dgani, Ram</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-4df85de995a664e37c2dd3da41f343b11f3fe34bb4b40e42d8a86e9ef502d6933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adjuvant therapy</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Combined Modality Therapy</topic><topic>Cystadenocarcinoma, Papillary - diagnosis</topic><topic>Cystadenocarcinoma, Papillary - therapy</topic><topic>Endometrial carcinoma</topic><topic>Ethnic Groups</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Logistic Models</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Papillary serous carcinoma</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the genital tract and mammary gland</topic><topic>Surgical stage</topic><topic>Survival Rate</topic><topic>Tropical medicine</topic><topic>Uterine Neoplasms - diagnosis</topic><topic>Uterine Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Piura, Benjamin</creatorcontrib><creatorcontrib>Meirovitz, Mihai</creatorcontrib><creatorcontrib>Shmulman, Michael</creatorcontrib><creatorcontrib>Yanai-Inbar, Ilana</creatorcontrib><creatorcontrib>Cohen, Yoram</creatorcontrib><creatorcontrib>Dgani, Ram</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Piura, Benjamin</au><au>Meirovitz, Mihai</au><au>Shmulman, Michael</au><au>Yanai-Inbar, Ilana</au><au>Cohen, Yoram</au><au>Dgani, Ram</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uterine papillary serous carcinoma: study of 19 cases</atitle><jtitle>European journal of obstetrics & gynecology and reproductive biology</jtitle><addtitle>Eur J Obstet Gynecol Reprod Biol</addtitle><date>1998-07-01</date><risdate>1998</risdate><volume>79</volume><issue>1</issue><spage>69</spage><epage>73</epage><pages>69-73</pages><issn>0301-2115</issn><eissn>1872-7654</eissn><coden>EOGRAL</coden><abstract>Objective: Uterine papillary serous carcinoma (UPSC) is an uncommon highly malignant variant of endometrial carcinoma that histologically and clinically resembles ovarian papillary serous carcinoma. The purpose of this study was to present the conjoined experience of two regional hospitals in the south of Israel (Soroka Medical Center, Beer-Sheva and Kaplan Hospital, Rehovot) of handling this tumour.
Study Design: Data from the files of 19 patients with UPSC who were managed at these hospitals between July 1991 and June 1997 were evaluated.
Results: The three-year survival rate was 57.3% overall; 83.3% for Stage I and 21.2% for Stages II, III, and IV combined (
P<0.02). Eighteen patients had primary surgery which included total abdominal hysterectomy and bilateral salpingo-oophorectomy and 15 (83.3%) of them received postoperative adjuvant therapy which included radiotherapy and/or systemic chemotherapy.
Conclusions: The prognosis of patients with UPSC is worse than that of patients with other forms of endometrial carcinoma. Primary surgery comprised of total abdominal hysterectomy, bilateral salpingo-oophorectomy and staging is the mainstay of treatment. The type of postoperative treatment is not consistent. By and large, adjuvant pelvic radiotherapy is usually given in early-stage disease and adjuvant systemic chemotherapy is usually prescribed in advanced-stage disease.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>9643407</pmid><doi>10.1016/S0301-2115(98)00039-6</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0301-2115 |
| ispartof | European journal of obstetrics & gynecology and reproductive biology, 1998-07, Vol.79 (1), p.69-73 |
| issn | 0301-2115 1872-7654 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_79965076 |
| source | ScienceDirect Freedom Collection |
| subjects | Adjuvant therapy Adult Aged Aged, 80 and over Animals Biological and medical sciences Combined Modality Therapy Cystadenocarcinoma, Papillary - diagnosis Cystadenocarcinoma, Papillary - therapy Endometrial carcinoma Ethnic Groups Female Follow-Up Studies Humans Logistic Models Medical sciences Middle Aged Papillary serous carcinoma Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the genital tract and mammary gland Surgical stage Survival Rate Tropical medicine Uterine Neoplasms - diagnosis Uterine Neoplasms - therapy |
| title | Uterine papillary serous carcinoma: study of 19 cases |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A40%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uterine%20papillary%20serous%20carcinoma:%20study%20of%2019%20cases&rft.jtitle=European%20journal%20of%20obstetrics%20&%20gynecology%20and%20reproductive%20biology&rft.au=Piura,%20Benjamin&rft.date=1998-07-01&rft.volume=79&rft.issue=1&rft.spage=69&rft.epage=73&rft.pages=69-73&rft.issn=0301-2115&rft.eissn=1872-7654&rft.coden=EOGRAL&rft_id=info:doi/10.1016/S0301-2115(98)00039-6&rft_dat=%3Cproquest_cross%3E79965076%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c389t-4df85de995a664e37c2dd3da41f343b11f3fe34bb4b40e42d8a86e9ef502d6933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79965076&rft_id=info:pmid/9643407&rfr_iscdi=true |